Francesco Izzo
National Cancer Institute of Naples, Italy
Dr Izzo is Principal Investigator of a number of national and international protocols in this field and has authored or co-authored more than 220 publications and 18 book chapters relating to the treatment of patients with HPB tumours. He is an active member of numerous professional societies, including the European Society of Surgical Oncology, the World Federation of Surgical Oncology, Society of Surgical Oncology and the American Society of Clinical Oncology.
Reviewing Interest
1) Surgical Oncology
2) Oncology
3) Hepatobiliary Cancer
4) Pancreatic cancer
5) Gastrointestinal cancer
6) Laparoscopy
Selected Publications:
1) Piccirillo M, Rinaldi L, Leongito M, Amore A, Crispo A, Granata V, Aprea P, Izzo F.
Percutaneous implant of Denver peritoneo-venous shunt for treatment of refractory ascites: a single center retrospective study.
Eur Rev Med Pharmacol Sci 2017; 21 (16): 3668-3673.
2) Granata V, Fusco R, Avallone A, Filice F, Tatangelo F, Piccirillo M, Grassi R, Izzo F, Petrillo A.
Critical analysis of the major and ancillary imaging features of LI-RADS on 127 proven HCCs evaluated with functional and morphological MRI: Lights and shadows.
Oncotarget 2017; 8 (31): 51224-51237.
3) Granata V, Fusco R, Setola SV, Piccirillo M, Leongito M, Palaia R, Granata F, Lastoria S, Izzo F, Petrillo A.
Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy.
World J Gastroenterol 2017; 23 (26): 4767-4778.
4) Granata V, Fusco R, Catalano O, Filice S, Avallone A, Piccirillo M, Leongito M, Palaia R, Grassi R, Izzo F, Petrillo A.
Uncommon neoplasms of the biliary tract: radiological findings.
Br J Radiol 2017; 90 (1078): 20160561.
5) Gentile I, Buonomo AR, Scotto R, Zappulo E, Carriero C, Piccirillo M, Izzo F, Rizzo M, Cerasuolo D, Borgia G, Cavalcanti E.
Diagnostic Accuracy of PIVKA-II, Alpha-Fetoprotein and a Combination of both in Diagnosis of Hepatocellular Carcinoma in Patients Affected by Chronic HCV Infection.
In Vivo 2017 Jul-Aug; 31 (4): 695-700.
6) Granata V, Fusco R, Catalano O, Avallone A, Palaia R, Botti G, Tatangelo F, Granata F, Cascella M, Izzo F, Petrillo A.
Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
PLoS One 2017; 12 (6): e0179951.
7) Bimonte S, Cascella M, Leongito M, Palaia R, Izzo F, Cuomo A.
An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer Recenti Prog Med 2017; 108 (6): 282-287.
8) Granata V, Fusco R, Avallone A, Leongito M, Izzo F, Petrillo A.
Peribiliary liver metastases MR findings.
Med Oncol 2017; 34 (7): 124.
9) Gentilini D, Scala S, Gaudenzi G, Garagnani P, Capri M, Cescon M, Grazi GL, Bacalini MG, Pisoni S, Dicitore A, Circelli L, Santagata S, Izzo F, Di Blasio AM, Persani L, Franceschi C, Vitale G.
Epigenome-wide association study in hepatocellular carcinoma: Identification of stochastic epigenetic mutations through an innovative statistical approach.
Oncotarget 2017; 8 (26): 41890-41902.
10) Gallo M, Malandrino P, Rota F, Izzo F, Faggiano A, Colao A. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectives.
J Cancer Res Clin Oncol 2017; 143 (7): 1209-1224.
11) Reginelli A, Granata V, Fusco R, Granata F, Rega D, Roberto L, Pellino G, Rotondo A, Selvaggi F, Izzo F, Petrillo A, Grassi R.
Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer.
Oncotarget 2017; 8 (14): 22980-22990.